Valuation: Boston Scientific Corporation

Market Cap 61.87B 55.41B 51.12B 46.26B 86.51B 5,891B 87.91B 610B 243B 3,083B 232B 227B 9,766B P/E 2026 *
17.3x
P/E 2027 * 18.3x
Enterprise Value 73.71B 66.02B 60.91B 55.12B 103B 7,019B 105B 727B 290B 3,674B 277B 271B 11,635B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.29x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day+0.61%
1 week-7.22%
Current month-2.20%
1 month-2.71%
3 months-7.28%
6 months-25.30%
Current year-55.23%
1 week 39.57
Extreme 39.57
46.07
1 month 39.57
Extreme 39.57
46.16
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
105.65
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Buy

Director

2,040 0.0001%
11/8/26 Other

Controller/Auditor

2,930 0.0002%
10/8/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%-7.22%-57.44%-13.79% 61.87B
+0.71%+4.82%+27.02%+64.39% 262B
+1.24%+3.15%+10.73%+26.13% 167B
+1.03%+1.11%-16.52%+73.28% 156B
+2.90%+4.83%+14.21%+53.04% 54.44B
+0.70%+2.71%-13.09%-6.48% 53.3B
-2.35%-3.79%+8.26%+63.75% 50.25B
-0.18%+4.18%+26.50%+76.27% 51.07B
+0.67%+5.37%+39.77%+96.14% 47.17B
+0.44%+7.67%+205.23%+165.57% 43.8B
Average +0.49%+2.28%+24.47%+59.83% 94.64B
Weighted average by Cap. +0.70%+2.68%+16.34%+56.23%

Financials

2026 *2027 *
Net sales 20.96B 18.78B 17.32B 15.68B 29.31B 1,996B 29.79B 207B 82.45B 1,045B 78.67B 77B 3,309B 21.11B 18.91B 17.44B 15.78B 29.51B 2,010B 29.99B 208B 83.01B 1,052B 79.21B 77.53B 3,332B
Net income 3.63B 3.25B 3B 2.71B 5.07B 346B 5.16B 35.77B 14.27B 181B 13.62B 13.33B 573B 3.55B 3.18B 2.94B 2.66B 4.97B 338B 5.05B 35.03B 13.97B 177B 13.33B 13.05B 561B
Net Debt 11.84B 10.61B 9.79B 8.86B 16.56B 1,128B 16.83B 117B 46.58B 590B 44.44B 43.5B 1,869B 7.67B 6.87B 6.34B 5.73B 10.72B 730B 10.9B 75.6B 30.16B 382B 28.78B 28.16B 1,210B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
29/10/26 USD 42.69 +0.61% 31,755,378
28/10/26 USD 42.43 -5.84% 69,837,060
27/10/26 USD 45.06 -1.14% 15,139,721
26/10/26 USD 45.58 -0.24% 11,928,715
23/10/26 USD 45.69 -0.70% 8,772,772
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
42.69USD
Average target price
51.99USD
Spread / Average Target
+21.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation